Researchers track Real-World effects of popular Weight-Loss drugs

NCT ID NCT06790160

First seen May 16, 2026 · Last updated May 16, 2026

Summary

This study follows 100 adults who are starting anti-obesity medications like semaglutide or tirzepatide. Researchers will measure changes in body fat, muscle, and strength over time, and look at how diet and exercise influence results. The goal is to understand the real-world impact of these drugs, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY AND OVERWEIGHT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Texas Tech University

    RECRUITING

    Lubbock, Texas, 79409, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.